Research Projects

Preclinical and translational development of an intratumoral immunotherapy strategy consisting of the combination of BO-112 and STING agonists (iTHER)

Imagen del Dr. Ignacio Melero Bermejo, especialista en Inmunología de la Clínica Universidad de Navarra.
Dr. Ignacio Melero Bermejo Curriculum
Researcher | Principal Investigator Combination Strategies for Translational Immunotherapy Research Group
Research Division
Cancer Division
Research program
Immunology and Immunotherapy
Research group
Combined translational immunotherapy strategies

Project information

Research project called Preclinical and translational development of an intratumoral immunotherapy strategy consisting of the combination of BO-112 and STING agonists (iTHER) and belonging to the Combined Translational Immunotherapy Strategies group of the Cima University of Navarra.

Led by Dr. Ignacio Melero and funded by PDC2021-121769-C21 and by MCIN/AEI/10.13039/501100011033 and the European Union ‘NextGenerationEU’/PRTR.

Translated with DeepL.com (free version)

Ministerio de Ciencia, Injnovación y Universidades. Unión Europea. Plan de RecuperaMinisterio de Ciencia, Injnovación y Universidades. Unión Europea. Plan de Recuperación, Transformación y Resiliencia. Agencia estatal de Investigación.ción, Transformación y Resiliencia. Agencia estatal de Investigación.

  • Convocation: Prueba de Concepto 2021
  • Reference: PDC2021-121769-C21
  • Start date: December 1, 2021
  • End date: June 30, 2024
  • Funders: Agencia Estatal de Investigación, Ministerio de Ciencia, Innovación y Universidades
  • Nature of project: National
  • Award year 2021

Need more information?

If you are interested in learning more about our research, please contact us.
 

GO TO ALL CIMA RESEARCH PROJECTS